Edgestream Partners L.P. Buys Shares of 22,264 Integer Holdings Co. (NYSE:ITGR)

Edgestream Partners L.P. bought a new stake in shares of Integer Holdings Co. (NYSE:ITGR) in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 22,264 shares of the medical equipment provider’s stock, valued at approximately $2,894,000. Edgestream Partners L.P. owned approximately 0.07% of Integer as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds have also made changes to their positions in the company. Price T Rowe Associates Inc. MD increased its position in shares of Integer by 6.8% during the first quarter. Price T Rowe Associates Inc. MD now owns 19,031 shares of the medical equipment provider’s stock valued at $2,221,000 after acquiring an additional 1,219 shares in the last quarter. Virtu Financial LLC bought a new stake in shares of Integer during the first quarter valued at approximately $298,000. GAMMA Investing LLC increased its position in shares of Integer by 60.9% during the second quarter. GAMMA Investing LLC now owns 375 shares of the medical equipment provider’s stock valued at $43,000 after acquiring an additional 142 shares in the last quarter. OLD National Bancorp IN bought a new stake in shares of Integer during the second quarter valued at approximately $248,000. Finally, QRG Capital Management Inc. increased its position in shares of Integer by 6.0% during the second quarter. QRG Capital Management Inc. now owns 33,251 shares of the medical equipment provider’s stock valued at $3,850,000 after acquiring an additional 1,883 shares in the last quarter. Institutional investors own 99.29% of the company’s stock.

Integer Trading Down 0.2 %

Shares of Integer stock opened at $140.50 on Monday. The company’s fifty day simple moving average is $131.38 and its 200-day simple moving average is $124.50. The stock has a market capitalization of $4.71 billion, a PE ratio of 43.36, a P/E/G ratio of 2.01 and a beta of 1.09. Integer Holdings Co. has a 1-year low of $84.75 and a 1-year high of $142.00. The company has a debt-to-equity ratio of 0.67, a current ratio of 3.28 and a quick ratio of 2.09.

Integer (NYSE:ITGR) last issued its quarterly earnings results on Thursday, October 24th. The medical equipment provider reported $1.43 earnings per share for the quarter, topping the consensus estimate of $1.36 by $0.07. Integer had a net margin of 6.70% and a return on equity of 11.63%. The business had revenue of $431.42 million for the quarter, compared to analysts’ expectations of $440.59 million. During the same quarter last year, the company posted $1.27 EPS. The company’s revenue was up 8.7% compared to the same quarter last year. As a group, equities analysts anticipate that Integer Holdings Co. will post 5.33 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several equities research analysts recently weighed in on the stock. Bank of America raised their price target on shares of Integer from $135.00 to $145.00 and gave the company a “buy” rating in a research report on Tuesday, October 1st. Piper Sandler reaffirmed an “overweight” rating and issued a $140.00 target price (up previously from $125.00) on shares of Integer in a research report on Friday, October 25th. Truist Financial cut their target price on shares of Integer from $150.00 to $147.00 and set a “buy” rating for the company in a research report on Friday, October 25th. KeyCorp lifted their target price on shares of Integer from $139.00 to $144.00 and gave the stock an “overweight” rating in a research report on Tuesday, October 15th. Finally, Benchmark lifted their target price on shares of Integer from $130.00 to $140.00 and gave the stock a “buy” rating in a research report on Monday, October 21st. One analyst has rated the stock with a hold rating and seven have given a buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $139.75.

Integer Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.